485 related articles for article (PubMed ID: 15553359)
1. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
[TBL] [Abstract][Full Text] [Related]
2. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
Kamath GS; Mittal S; Sherrid MV
Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
[TBL] [Abstract][Full Text] [Related]
3. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
4. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
[TBL] [Abstract][Full Text] [Related]
5. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
Takahashi A; Shiga T; Shoda M; Manaka T; Ejima K; Hagiwara N
Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
[TBL] [Abstract][Full Text] [Related]
6. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
[TBL] [Abstract][Full Text] [Related]
9. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
[TBL] [Abstract][Full Text] [Related]
10. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
[No Abstract] [Full Text] [Related]
11. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
12. Long QT syndrome and dilated cardiomyopathy with SCN5A p.R1193Q polymorphism: cardioverter-defibrillator implantation at 27 months.
Kwon HW; Lee SY; Kwon BS; Kim GB; Bae EJ; Kim WH; Noh CI; Cho SI; Park SS
Pacing Clin Electrophysiol; 2012 Aug; 35(8):e243-6. PubMed ID: 22519808
[TBL] [Abstract][Full Text] [Related]
13. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
14. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
[TBL] [Abstract][Full Text] [Related]
15. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents].
Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M
Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095
[TBL] [Abstract][Full Text] [Related]
16. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
17. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
18. Risks and challenges of implantable cardioverter-defibrillators in young adults.
Sherrid MV; Daubert JP
Prog Cardiovasc Dis; 2008; 51(3):237-63. PubMed ID: 19026858
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
20. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
